Concordantly with the idea that P‐cadherin associates with more aggressive cancers, our study established P‐cadherin as a novel oncogenic player in GBM, affecting cell viability, cell cycle, cell invasion, migration, and neurosphere formation (Figs 2 and 3; Figs S4–S6). This evidence concerns the gene CDH3 and glioblastoma.